1. Home
  2. QDEL vs MRVI Comparison

QDEL vs MRVI Comparison

Compare QDEL & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuidelOrtho Corporation

QDEL

QuidelOrtho Corporation

HOLD

Current Price

$13.33

Market Cap

989.5M

Sector

Health Care

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

SELL

Current Price

$7.06

Market Cap

1.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
QDEL
MRVI
Founded
1979
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
989.5M
1.1B
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
QDEL
MRVI
Price
$13.33
$7.06
Analyst Decision
Hold
Buy
Analyst Count
3
9
Target Price
★ $14.67
$8.50
AVG Volume (30 Days)
2.0M
★ 2.3M
Earning Date
11-03-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 45.35
14.29
EPS
N/A
★ N/A
Revenue
★ $2,730,200,000.00
$185,743,000.00
Revenue This Year
N/A
$14.01
Revenue Next Year
$1.85
$6.20
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$9.92
$2.55
52 Week High
$35.58
$9.42

Technical Indicators

Market Signals
Indicator
QDEL
MRVI
Relative Strength Index (RSI) 53.87 47.36
Support Level $13.04 $6.41
Resistance Level $17.86 $7.60
Average True Range (ATR) 1.09 0.54
MACD 0.19 -0.02
Stochastic Oscillator 67.80 28.51

Price Performance

Historical Comparison
QDEL
MRVI

About QDEL QuidelOrtho Corporation

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Share on Social Networks: